Establishment and Validation of an Automated System for the Antifactor IIa Assay: A Case Study of Potency Assessment of a Pharmaceutical Gel FormulationACS OMEGAIF4.32024-04-131OAAI
Potential protective effects of hydroxypropyl-β-cyclodextrin on Aβ(1-42)-induced neurotoxicityFREE RADICAL BIOLOGY AND MEDICINEIF8.22018-05-010PREAI
Effect of GCEE or GCEE-loaded microspheres Administration on the Levels of Glutathione and Thiol Redox Molecules in Rat BrainFREE RADICAL BIOLOGY AND MEDICINEIF8.22017-07-010PREAI
Neuroprotective Effects of Engineered Polymeric Nasal Microspheres Containing Hydroxypropyl-β-cyclodextrin on β-Amyloid (1-42)-Induced ToxicityJOURNAL OF PHARMACEUTICAL SCIENCESIF3.82016-08-0131PREAI
Effects of nicotinamide treatment on mRNA expression of various enzymes involved in NAD+ metabolism in Aβ(1-42) induced neurodegenerationFREE RADICAL BIOLOGY AND MEDICINEIF8.22016-07-010PREAI
STAT-dependent upregulation of 12/15-lipoxygenase contributes to neuronal injury after strokeJOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISMIF4.52015-07-1545OAAI
Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ (1-42)-induced rat model of Alzheimer's diseaseFREE RADICAL RESEARCHIF2.92013-11-11145PREAI
1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BuChE, and amyloid-β aggregation crossing the blood-brain barrier1,4-取代的4-(1h)-吡啶基-hydr型AChE,BuChE和淀粉样蛋白-β 聚集穿过血脑屏障的抑制剂EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESIF4.72013-07-0137PREAI
Effects of resveratrol on hydrogen peroxide-induced oxidative stress in embryonic neural stem cellsNEURAL REGENERATION RESEARCHIF6.72013-02-2558PRE
Neuroprotective effects of PARP-1 inhibitors on the model of Alzheimer's Disease induced by Aβ(1-42)FREE RADICAL BIOLOGY AND MEDICINEIF8.22012-09-010PREAI
Kainic acid-induced changes in the opioid/nociceptin system and the stress/toxicity pathways in the rat hippocampusNEUROCHEMISTRY INTERNATIONALIF42012-05-018PREAI
Neuroprotection by mefenamic acid against D-serine: Involvement of oxidative stress, inflammation and apoptosisFREE RADICAL RESEARCHIF2.92012-03-1617PREAI
Changes in the cannabinoid (CB1) receptor expression level and G-protein activation in the kainic acid model of epilepsyPHARMACOLOGICAL REPORTSIF3.82011-01-010PREAI
Potential neuroprotective effect of γ-glutamylcysteine ethyl ester on rat brain against kainic acid-induced excitotoxicityFREE RADICAL RESEARCHIF2.92010-03-1015PREAI
Studies on Mefenamic Acid Microparticles: Formulation, In Vitro Release, and In Situ Studies in RatsAAPS PHARMSCITECHIF42009-01-2913OAAI